DDI HV (ATV - Merck)

NCT00518297 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir
DRUG: Atazanavir
DRUG: Atazanavir + Raltegravir

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]